LASIK Flap Thickness and Visual Outcomes Using the WaveLight FS200 Femtosecond Laser (FS200)
Primary Purpose
Myopia
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
FS200 femtosecond laser LASIK
IntraLase femtosecond laser LASIK
Sponsored by
About this trial
This is an interventional treatment trial for Myopia
Eligibility Criteria
Inclusion Criteria:
- All patients with ametropia (Spherical, spherocylindrical, presbyopic) suitable for treatment by LASIK, including different target refractions (Plano or Monovision).
Exclusion Criteria:
- Patients unsuitable for LASIK procedure because of an estimated residual stromal bed < 300 microns after calculation of the ablation (Corneal thickness - flap thickness - simulated stromal ablation for the desired correction).
- Patients unsuitable for LASIK due suspicious topography for ectasia, form frust keratoconus or unstable ( more than 0.50 diopter change in sphere or cylinder in the last year) refraction.
- Patients with amblyopia or any eye disease that might limit the visual recovery.
- Patients younger than 18 years old.
Sites / Locations
- Cleveland Clinic
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
FS200 femtosecond laser LASIK
IntraLase femtosecond laser LASIK
Arm Description
LASIK flap created with an FS200 femtosecond laser system
LASIK flap created with an IntraLase femtosecond laser system
Outcomes
Primary Outcome Measures
Evaluation of LASIK Flap Thickness
Central LASIK flap thickness for each femtosecond laser. Each treatment was set for a 110 micrometer thick flap.
Secondary Outcome Measures
Full Information
NCT ID
NCT02060461
First Posted
December 16, 2013
Last Updated
February 22, 2018
Sponsor
The Cleveland Clinic
Collaborators
Alcon Research
1. Study Identification
Unique Protocol Identification Number
NCT02060461
Brief Title
LASIK Flap Thickness and Visual Outcomes Using the WaveLight FS200 Femtosecond Laser
Acronym
FS200
Official Title
LASIK Flap Thickness and Visual Outcomes Using the WaveLight FS200 Femtosecond Laser: 3 Months Follow-up of Initial US Clinical Series
Study Type
Interventional
2. Study Status
Record Verification Date
February 2018
Overall Recruitment Status
Completed
Study Start Date
August 2012 (undefined)
Primary Completion Date
September 2015 (Actual)
Study Completion Date
September 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The Cleveland Clinic
Collaborators
Alcon Research
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The objective of this study is to evaluate the visual outcome, accuracy, predictability and complications of LASIK flap creation using the Alcon Wavelight FS200 Femtosecond laser and compare these results to those obtained using current IntraLase FS60 Femtosecond laser. The primary outcome to be evaluated is the flap thickness accuracy.
Detailed Description
Laser in situ keratomileusis (LASIK) is a method for treating myopia, hyperopia and astigmatism. In LASIK, the cornea is reshaped to focus images more clearly on the retina without the aid of glasses or contact lenses. LASIK involves two steps: creation of a corneal flap, which can be performed by a mechanical microkeratome or a femtosecond laser, and reshaping of the cornea by another laser, an excimer laser.
The accuracy of the LASIK flap thickness is a key safety consideration to reduce the likelihood of complications following LASIK. Femtosecond laser technology has significantly improved the predictability of LASIK flap dimensions while supporting similar visual acuity results.
The Alcon FS200 femtosecond laser is approved for human use by the United States Food and Drug Administration and was recently released in the US market. This study will directly compare outcomes of LASIK performed with this newer laser to those performed with the AMO IntraLase femtosecond laser.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myopia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Contralateral eye study
Masking
None (Open Label)
Allocation
Randomized
Enrollment
33 (Actual)
8. Arms, Groups, and Interventions
Arm Title
FS200 femtosecond laser LASIK
Arm Type
Experimental
Arm Description
LASIK flap created with an FS200 femtosecond laser system
Arm Title
IntraLase femtosecond laser LASIK
Arm Type
Experimental
Arm Description
LASIK flap created with an IntraLase femtosecond laser system
Intervention Type
Device
Intervention Name(s)
FS200 femtosecond laser LASIK
Other Intervention Name(s)
Alcon FS200 femtosecond laser
Intervention Type
Device
Intervention Name(s)
IntraLase femtosecond laser LASIK
Other Intervention Name(s)
AMO IntraLase femtosecond laser
Primary Outcome Measure Information:
Title
Evaluation of LASIK Flap Thickness
Description
Central LASIK flap thickness for each femtosecond laser. Each treatment was set for a 110 micrometer thick flap.
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
All patients with ametropia (Spherical, spherocylindrical, presbyopic) suitable for treatment by LASIK, including different target refractions (Plano or Monovision).
Exclusion Criteria:
Patients unsuitable for LASIK procedure because of an estimated residual stromal bed < 300 microns after calculation of the ablation (Corneal thickness - flap thickness - simulated stromal ablation for the desired correction).
Patients unsuitable for LASIK due suspicious topography for ectasia, form frust keratoconus or unstable ( more than 0.50 diopter change in sphere or cylinder in the last year) refraction.
Patients with amblyopia or any eye disease that might limit the visual recovery.
Patients younger than 18 years old.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
William J Dupps, MD, PhD
Organizational Affiliation
The Cleveland Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cleveland Clinic
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
24792107
Citation
Rocha KM, Krueger RR. Spectral-domain optical coherence tomography epithelial and flap thickness mapping in femtosecond laser-assisted in situ keratomileusis. Am J Ophthalmol. 2014 Aug;158(2):293-301.e1. doi: 10.1016/j.ajo.2014.04.012. Epub 2014 Apr 30.
Results Reference
result
Learn more about this trial
LASIK Flap Thickness and Visual Outcomes Using the WaveLight FS200 Femtosecond Laser
We'll reach out to this number within 24 hrs